Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |